◆ NeutralAMIX

Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study

GlobeNewswire Inc.·
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study

Autonomix Medical announced positive preclinical study results showing its neural sensing platform can detect, localize, and confirm changes in renal neural activity. The technology enables physiological feedback during renal denervation procedures, potentially addressing current limitations where physicians rely on anatomical landmarks rather than direct neural information. The company plans further preclinical and clinical studies to evaluate physiology-guided renal denervation applications.

Read Full Article at GlobeNewswire Inc.
← Back to Financial Intelligence